Your account is not claimed yet. You can sign up with ORCID to claim your account.

Phil Fang Cheng (Phil F Cheng, Phil Cheng, P F Cheng)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 21

Top Venues

Cancer research

Nature communications

Cancers

Non-coding RNA

University Hospital of Zurich

University of Zurich (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital of Zurich Mar 1o 2015

Switzerland

Post-doctoral Researcher :: Dermatology

Education History

University of Zurich Nov 22o 2009 - Mar 1o 2015

Switzerland

PHD :: Cancer Biology

Publications

Ossia M Eichhoff, Corinne I Stoffel, Jan Käsler, Luzia Briker, Patrick Turko, Gergely Karsai, Nina Zila, Verena Paulitschke, Phil Fang Cheng, Alexander Leitner, Andrea Bileck, Nicola Zamboni, Anja Irmisch, Zsolt Balazs, Aizhan Tastanova, Susana Pascoal, Pål Johansen, Rebekka Wegmann, Julien Mena, Alaa Othman, Vasanthi S Viswanathan, Judith Wenzina, Andrea Aloia, Annalisa Saltari, Andreas Dzung, null null, Rudolf Aebersold, Melike Ak, Faisal S Al-Quaddoomi, Silvana I Albert, Jonas Albinus, Ilaria Alborelli, Sonali Andani, Per-Olof Attinger, Marina Bacac, Daniel Baumhoer, Beatrice Beck-Schimmer, Niko Beerenwinkel, Christian Beisel, Lara Bernasconi, Anne Bertolini, Bernd Bodenmiller, Ximena Bonilla, Lars Bosshard, Byron Calgua, Ruben Casanova, Stéphane Chevrier, Natalia Chicherova, Ricardo Coelho, Maya D'Costa, Esther Danenberg, Natalie Davidson, Monica-Andreea Drãgan, Reinhard Dummer, Stefanie Engler, Martin Erkens, Katja Eschbach, Cinzia Esposito, André Fedier, Pedro Ferreira, Joanna Ficek, Anja L Frei, Bruno Frey, Sandra Goetze, Linda Grob, Gabriele Gut, Detlef Günther, Martina Haberecker, Pirmin Haeuptle, Viola Heinzelmann-Schwarz, Sylvia Herter, Rene Holtackers, Tamara Huesser, Alexander Immer, Anja Irmisch, Francis Jacob, Andrea Jacobs, Tim M Jaeger, Katharina Jahn, Alva R James, Philip M Jermann, André Kahles, Abdullah Kahraman, Viktor H Koelzer, Werner Kuebler, Jack Kuipers, Christian P Kunze, Christian Kurzeder, Kjong-Van Lehmann, Mitchell Levesque, Ulrike Lischetti, Sebastian Lugert, Gerd Maass, Markus G Manz, Philipp Markolin, Martin Mehnert, Julien Mena, Julian M Metzler, Nicola Miglino, Emanuela S Milani, Holger Moch, Simone Muenst, Riccardo Murri, Charlotte Ky Ng, Stefan Nicolet, Marta Nowak, Monica Nunez Lopez, Patrick Ga Pedrioli, Lucas Pelkmans, Salvatore Piscuoglio, Michael Prummer, Natalie Rimmer, Mathilde Ritter, Christian Rommel, María L Rosano-González, Gunnar Rätsch, Natascha Santacroce, Jacobo Sarabia Del Castillo, Ramona Schlenker, Petra C Schwalie, Severin Schwan, Tobias Schär, Gabriela Senti, Wenguang Shao, Franziska Singer, Sujana Sivapatham, Berend Snijder, Bettina Sobottka, Vipin T Sreedharan, Stefan Stark, Daniel J Stekhoven, Tanmay Tanna, Alexandre Pa Theocharides, Tinu M Thomas, Markus Tolnay, Vinko Tosevski, Nora C Toussaint, Mustafa A Tuncel, Marina Tusup, Audrey Van Drogen, Marcus Vetter, Tatjana Vlajnic, Sandra Weber, Walter P Weber, Rebekka Wegmann, Michael Weller, Fabian Wendt, Norbert Wey, Andreas Wicki, Mattheus He Wildschut, Bernd Wollscheid, Shuqing Yu, Johanna Ziegler, Marc Zimmermann, Martin Zoche, Gregor Zuend, Michael Krauthammer, Stuart L Schreiber, Thorsten Hornemann, Martin Distel, Berend Snijder, Reinhard Dummer, Mitchell Paul Levesque
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma. Cancer research (2023)
Nina Zila, Ossia M Eichhoff, Irene Steiner, Thomas Mohr, Andrea Bileck, Phil Fang Cheng, Alexander Leitner, Ludovic C J Gillet, Tatjana Sajic, Sandra Goetze, Betty Friedrich, Patricia Bortel, Johanna Strobl, René Reitermaier, Sabrina A Hogan, Julia Martínez Gómez, Ramon Staeger, Felix Tuchmann, Sophie Peters, Georg Stary, Mario Kuttke, Adelheid Elbe-Buerger, Christoph Hoeller, Rainer Kunstfeld, Wolfgang Weninger, Bernd Wollscheid, Reinhard Dummer, Lars Einar French, Christopher Gerner, Ruedi Aebersold, Mitchell Paul Levesque, Verena Paulitschke
Proteomic profiling of advanced melanoma patients to predict therapeutic response to anti-PD-1 therapy. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ossia M Eichhoff, Corinne I Stoffel, Jan Käsler, Luzia Briker, Patrick Turko, Gergely Karsai, Nina Zila, Verena Paulitschke, Phil Fang Cheng, Alexander Leitner, Andrea Bileck, Nicola Zamboni, Anja Irmisch, Zsolt Balazs, Aizhan Tastanova, Susana Pascoal, Pål Johansen, Rebekka Wegmann, Julien Mena, Alaa Othman, Vasanthi S Viswanathan, Judith Wenzina, Andrea Aloia, Annalisa Saltari, Andreas Dzung, null null, Michael Krauthammer, Stuart L Schreiber, Thorsten Hornemann, Martin Distel, Berend Snijder, Reinhard Dummer, Mitchell Paul Levesque
ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma. Cancer research (2023)
Lukas Kraehenbuehl, Stephanie Schneider, Laura Pawlik, Joanna Mangana, Phil Fang Cheng, Reinhard Dummer, Barbara Meier-Schiesser
Cutaneous Adverse Events of Systemic Melanoma Treatments: A Retrospective Single-Center Analysis. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Markus Haake, Beatrice Haack, Tina Schäfer, Patrick N Harter, Greta Mattavelli, Patrick Eiring, Neha Vashist, Florian Wedekink, Sabrina Genssler, Birgitt Fischer, Julia Dahlhoff, Fatemeh Mokhtari, Anastasia Kuzkina, Marij J P Welters, Tamara M Benz, Lena Sorger, Vincent Thiemann, Giovanni Almanzar, Martina Selle, Klara Thein, Jacob Späth, Maria Cecilia Gonzalez, Carmen Reitinger, Andrea Ipsen-Escobedo, Kilian Wistuba-Hamprecht, Kristin Eichler, Katharina Filipski, Pia S Zeiner, Rudi Beschorner, Renske Goedemans, Falk Hagen Gogolla, Hubert Hackl, Rogier W Rooswinkel, Alexander Thiem, Paula Romer Roche, Hemant Joshi, Dirk Pühringer, Achim Wöckel, Joachim E Diessner, Manfred Rüdiger, Eugen Leo, Phil Fang Cheng, Mitchell Paul Levesque, Matthias Goebeler, Markus Sauer, Falk Nimmerjahn, Christine Schuberth-Wagner, Stefanie von Felten, Michel Mittelbronn, Matthias Mehling, Andreas Beilhack, Sjoerd H van der Burg, Angela Riedel, Benjamin Weide, Reinhard Dummer, Jörg Wischhusen
Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. Nature communications 14 (1) (2023)
E L Looman, Phil Fang Cheng, J Lai-Kwon, L Morgan, M Wakkee, R Dummer, Florentia Dimitriou
Health-related quality of life in survivors of advanced melanoma treated with anti-PD1-based immune checkpoint inhibitors. Cancer medicine (2023)
Lorenza P Ferretti, Flurina Böhi, Deena M Leslie Pedrioli, Phil Fang Cheng, Elena Ferrari, Petra Baumgaertner, Abdiel Alvarado-Diaz, Federica Sella, Alessandra Cereghetti, Patrick Turko, Roni H G Wright, Katrien De Bock, Daniel E Speiser, Roberto Ferrari, Mitchell Paul Levesque, Michael O Hottiger
Combinatorial treatment with PARP and MAPK inhibitors overcomes phenotype switch-driven drug resistance in advanced melanoma. Cancer research (2023)
Sarah A Nadeau, Timothy G Vaughan, Christiane Beckmann, Ivan Topolsky, Chaoran Chen, Emma B Hodcroft, Tobias Schär, Ina Nissen, Natascha Santacroce, Elodie Burcklen, Pedro Ferreira, Kim Philipp Jablonski, Susana Posada Céspedes, Vincenzo Capece, Sophie Seidel, Noemi Santamaria de Souza, Julia Martínez Gómez, Phil Fang Cheng, Philipp Peter Bosshard, Mitchell Paul Levesque, Verena Kufner, Stefan Schmutz, Maryam Zaheri, Michael Huber, Alexandra Trkola, Samuel Cordey, Florian Laubscher, Ana Rita Gonçalves, Sébastien Aeby, Trestan Pillonel, Damien Jacot, Claire Bertelli, Gilbert Greub, Karoline Leuzinger, Madlen Stange, Alfredo Mari, Tim Roloff, Helena Seth-Smith, Hans H Hirsch, Adrian Egli, Maurice Redondo, Olivier Kobel, Christoph Noppen, Louis du Plessis, Niko Beerenwinkel, Richard A Neher, Christian Beisel, Tanja Stadler
Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data. Science translational medicine (2022)
Anna Sophie Jahn, Alexander Andreas Navarini, Sara Elisa Cerminara, Lisa Kostner, Stephanie Marie Huber, Michael Kunz, Julia-Tatjana Maul, Reinhard Dummer, Seraina Sommer, Anja Dominique Neuner, Mitchell Paul Levesque, Phil Fang Cheng, Lara Valeska Maul
Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients' Perception. Cancers 14 (15) (2022)
Marina Tusup, Phil Fang Cheng, Ernesto Picardi, Austeja Raziunaite, Reinhard Dummer, Mitchell Paul Levesque, Lars Einar French, Emmanuella Guenova, Thomas M Kundig, Natalia Teresa Jarzebska
Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7 , 5. Non-coding RNA 8 (6) (2022)
Aurelio Boerlin, Elisa Bellini, Patrick Turko, Phil Fang Cheng, Mitchell Paul Levesque, Reinhard Dummer, Egle Ramelyte
The Prognostic Value of a Single, Randomly Timed Circulating Tumor DNA Measurement in Patients with Metastatic Melanoma. Cancers 14 (17) (2022)
Ismael A Vergara, Christopher P Mintoff, Shahneen Sandhu, Lachlan McIntosh, Richard J Young, Stephen Q Wong, Andrew Colebatch, Daniel L Cameron, Julia Lai Kwon, Rory Wolfe, Angela Peng, Jason Ellul, Xuelin Dou, Clare Fedele, Samantha Boyle, Gisela Mir Arnau, Jeanette Raleigh, Athena Hatzimihalis, Pacman Szeto, Jennifer Mooi, Daniel S Widmer, Phil Fang Cheng, Valerie Amann, Reinhard Dummer, Nicholas K Hayward, James S Wilmott, Richard A Scolyer, Raymond J Cho, David Bowtell, Heather Thorne, Kathryn Alsop, Stephen Cordner, Noel Woodford, Jodie Leditschke, Patricia O'Brien, Sarah-Jane Dawson, Grant A McArthur, Graham J Mann, Mitchell P Levesque, Anthony T Papenfuss, Mark Shackleton
Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling. Nature communications 12 (1) (2021)
Florentia Dimitriou, Ramon Staeger, Melike Ak, Matias Maissen, Ken Kudura, Marjam J Barysch, Mitchell Paul Levesque, Phil Fang Cheng, Reinhard Dummer, Joanna Mangana
Frequency, Treatment and Outcome of Immune-Related Toxicities in Patients with Immune-Checkpoint Inhibitors for Advanced Melanoma: Results from an Institutional Database Analysis. Cancers 13 (12) (2021)
Annalisa Saltari, Andreas Dzung, Marika Quadri, Natascia Tiso, Nicola Facchinello, Alberto Hernández-Barranco, Susana Garcia-Silva, Laura Nogués, Corinne Isabelle Stoffel, Phil Fang Cheng, Patrick Turko, Ossia M Eichhoff, Francesca Truzzi, Alessandra Marconi, Carlo Pincelli, Hector Peinado, Reinhard Dummer, Mitchell P Levesque
Specific Activation of the CD271 Intracellular Domain in Combination with Chemotherapy or Targeted Therapy Inhibits Melanoma Progression. Cancer research 81 (23) (2021)
Johanna Diener, Arianna Baggiolini, Mattias Pernebrink, Damian Dalcher, Luigi Lerra, Phil Fang Cheng, Sandra Varum, Jessica Häusel, Salome Stierli, Mathias Treier, Lorenz Studer, Konrad Basler, Mitchell P Levesque, Reinhard Dummer, Raffaella Santoro, Claudio Cantú, Lukas Sommer
Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4. Nature communications 12 (1) (2021)
Ramile Dilshat, Valerie Fock, Colin Kenny, Ilse Gerritsen, Romain Maurice Jacques Lasseur, Jana Travnickova, Ossia M Eichhoff, Philipp Cerny, Katrin Möller, Sara Sigurbjörnsdóttir, Kritika Kirty, Berglind Ósk Einarsdottir, Phil Fang Cheng, Mitchell Levesque, Robert A Cornell, E Elizabeth Patton, Lionel Larue, Marie de Tayrac, Erna Magnusdottir, Margrét Helga Ögmundsdóttir, Eirikur Steingrimsson
MITF reprograms the extracellular matrix and focal adhesion in melanoma. eLife 10 (2021)
Marina Tusup, Phil Fang Cheng, Ernesto Picardi, Austeja Raziunaite, Reinhard Dummer, Mitchell Paul Levesque, Lars Einar French, Emmanuella Guenova, Thomas M Kundig, Steve Pascolo
Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-coding RNA 7 (1) (2021)
Niels Vandamme, Geertrui Denecker, Kenneth Bruneel, Gillian Blancke, Özden Akay, Joachim Taminau, Jordy De Coninck, Eva De Smedt, Nicolas Skrypek, Wouter Van Loocke, Jasper Wouters, David Nittner, Corinna Köhler, Douglas S Darling, Phil Fang Cheng, Marieke I G Raaijmakers, Mitchell P Levesque, Udupi Girish Mallya, Mairin Rafferty, Balazs Balint, William M Gallagher, Lieve Brochez, Danny Huylebroeck, Jody J Haigh, Vanessa Andries, Florian Rambow, Pieter Van Vlierberghe, Steven Goossens, Joost J van den Oord, Jean-Christophe Marine, Geert Berx
The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-Like Phenotype. Cancer research 80 (14) (2020)
Jessica L F Teh, Dan A Erkes, Phil Fang Cheng, Manoela Tiago, Nicole A Wilski, Conroy O Field, Inna Chervoneva, Mitch P Levesque, Xiaowei Xu, Reinhard Dummer, Andrew E Aplin
Activation of CD8+ T Cells Contributes to Antitumor Effects of CDK4/6 Inhibitors plus MEK Inhibitors. Cancer immunology research 8 (9) (2020)
Michael Bauer, Zuzana Nascakova, Anca-Irina Mihai, Phil Fang Cheng, Mitchell P Levesque, Simon Lampart, Robert Hurwitz, Lennart Pfannkuch, Jana Dobrovolna, Melanie Jacobs, Sina Bartfeld, Anders Dohlman, Xiling Shen, Alevtina A Gall, Nina R Salama, Antonia Töpfer, Achim Weber, Thomas F Meyer, Pavel Janscak, Anne Müller
The ALPK1/TIFA/NF-κB axis links a bacterial carcinogen to R-loop-induced replication stress. Nature communications 11 (1) (2020)
Sabrina A Hogan, Anaïs Courtier, Phil Fang Cheng, Nicoletta F Jaberg-Bentele, Simone M Goldinger, Manuarii Manuel, Solène Perez, Nadia Plantier, Jean-François Mouret, Thi Dan Linh Nguyen-Kim, Marieke I G Raaijmakers, Pia Kvistborg, Nicolas Pasqual, John B A G Haanen, Reinhard Dummer, Mitchell P Levesque
Peripheral Blood TCR Repertoire Profiling May Facilitate Patient Stratification for Immunotherapy against Melanoma. Cancer immunology research 7 (1) (2018)

Phil Fang Cheng.css-eqlu8i{font-size:small;padding-left:4px;} (Phil F Cheng, Phil Cheng, P F Cheng)

Publication Activity (10 Years)

Top Topics

Top Venues

Phil Fang Cheng (Phil F Cheng, Phil Cheng, P F Cheng)